Huachuang Securities: It was first rated as "recommended" by Zangge Mining, with a target price of 33.3 yuan. Huachuang Securities Research Report pointed out that Zangge Mining (000408.SZ) is an important producer of potassium lithium salt and copper in China, with a high dividend return to shareholders. The company actively arranges high-quality potash resources at home and abroad: three major projects, namely, Heibei potash mine in Dalangtan, Alkali-Shishan potash mine and the eastern part of deep brine potash mine in Xiaoliangshan-Dafengshan area, are steadily promoted in China, with a total exploration right of 1,400 square kilometers; Overseas has signed a potash exploration agreement with Laos. At present, the exploration report and potash mine reserve certificate have been obtained. It is estimated that the total amount of potassium chloride resources in Setani County and Ba 'e County is 984 million tons. It is estimated that the output of the first phase of potassium chloride project will be 1 million tons/year, and the scale of potassium chloride production is expected to double in the future. The company is an important manufacturer of potassium and lithium in China, and Julong Copper is expected to inject strong kinetic energy into the company's growth. Considering that Mamicho Mining has not been consolidated at present, it is estimated that the company will realize a net profit of 25.0/27.7/4.29 billion yuan in 24-26 years, which is -27%, +11% and +54.9% respectively. In 2025, it can be compared with the company's average valuation of 19 times, giving the company a valuation of 19 times in 2025, corresponding to the target price of 33.3 yuan, covering for the first time and giving a "recommended" rating.The latest collection price of the heavy anticancer star drug Regofibril has dropped to a minimum of more than 4 yuan per tablet. The reporter learned at the scene of the tenth batch of drug collection that the anti-tumor drug Regofibril tablets with annual sales of more than 1 billion yuan have been auctioned by this collection, and the price has almost dropped to between 4 yuan and 6 yuan, which is 90% lower than the price limit. Nanjing Zhengda Tianqing is expected to win the bid in the first round of quotation. Regofibril can treat colorectal cancer, liver cancer and other cancers. Its original research manufacturer is Bayer, which occupies almost all the market share in China. The price of this collection is about 172 yuan per tablet. (science and technology innovation board Daily)Market news: Brazilian President Lula should be able to leave the hospital early next week.
The employees of Extreme Vietnam accused CEO Xia Yiping of being suspected of corruption. For the predicament of Extreme Vietnam, some employees of Extreme Vietnam accused Xia Yiping of being suspected of corruption in the circle of friends. He said, "When I asked to organize the media competitive presentation according to the procurement process, he forced the suppliers to come in; When his supplier was not shortlisted, he refused to sign the framework; When his people took a few pages of A4 paper, they asked me to examine and approve all the muddled accounts before I took office. When I witnessed with my own eyes, he specially approved the supplier designated by his people who paid ten times the market price. " In the intimate colleague circle, some employees also said, "Before 4 o'clock yesterday afternoon, if Xia Yiping resigned himself, the money could still be transferred to the Jidu account, and Jidu could still revitalize all the situations. However, Xia Yiping is determined not to resign, and then he will drag everyone with him. After Baidu sent a new financial controller to audit the company in October, it discovered Xia Yiping's corruption, private giving and receiving behavior, purchasing various designated suppliers and pocketing his own money. Therefore, Xia Yiping was asked to resign on his own. " The above statement has not been confirmed by the extreme Vietnamese side. (Sina Technology)Leshan Guotou Group and others set up an industrial guidance equity investment fund with a capital contribution of 4.5 billion yuan. According to Tianyancha App, recently, Leshan Jiarong Industrial Guidance Equity Investment Fund Partnership (Limited Partnership) was established, and the executive partner is Leshan Guorong Equity Investment Fund Management Co., Ltd., with a capital contribution of 4.5 billion yuan, and its business scope includes investment activities with its own funds. According to the partner information, the fund is jointly funded by Leshan State-owned Assets Investment and Operation (Group) Co., Ltd., Leshan Finance Bureau and Leshan Guorong Equity Investment Fund Management Co., Ltd.India imported 841,993 tons of palm oil in November, compared with 845,682 tons in October.
Market news: Brazilian President Lula should be able to leave the hospital early next week.The European Central Bank cut interest rates by 25 basis points, warning that economic growth will slow down. The European Central Bank cut interest rates by 25 basis points to 3%, and warned that economic growth will be weaker than its previous forecast. This is the fourth time that the European Central Bank has cut interest rates since June, bringing the benchmark interest rate to its lowest level since March 2023. At the same time, the European Central Bank warned that the euro zone economy will only grow by 1.1% in 2025, lower than its forecast of 1.3% in September. It was widely expected that the European Central Bank would cut interest rates. Investors expect that the European Central Bank will cut interest rates more than the Federal Reserve next year, because it is widely expected that the economic growth of the euro zone will lag behind that of the United States. The euro zone's export-dependent economy is also vulnerable to Trump's threat to impose tariffs of up to 20% on all American imports.ECB: Most indicators show that the inflation rate will stabilize at 2%.